tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

INMB Stock Latest News

INmune Bio Approves Option Repricing Proposal
Company AnnouncementsINmune Bio Approves Option Repricing Proposal
9d ago
8K
INMB
Inmune Bio Advances Immunotherapy Pipeline with Phase 2 Completion
PremiumCompany Announcements
Inmune Bio Advances Immunotherapy Pipeline with Phase 2 Completion
17d ago
8K
INMB
Inmune Bio’s Earnings Call Highlights Progress and Challenges
PremiumCompany Announcements
Inmune Bio’s Earnings Call Highlights Progress and Challenges
27d ago
INMB
Inmune Bio Reports Q3 2025 Financial Results
PremiumCompany Announcements
Inmune Bio Reports Q3 2025 Financial Results
27d ago
INMB
INmune Bio reports Q3 EPS (24c), consensus (32c)
PremiumThe Fly
INmune Bio reports Q3 EPS (24c), consensus (32c)
28d ago
INMB
Inmune Bio to Host Q3 Results Conference Call
PremiumCompany AnnouncementsInmune Bio to Host Q3 Results Conference Call
30d ago
8K
INMB
INmune Bio CEO to Speak at Maxim Growth Summit
Premium
Company Announcements
INmune Bio CEO to Speak at Maxim Growth Summit
1M ago
8K
INMB
Inmune Bio’s Promising Pipeline and Strategic Positioning Support Buy Rating Despite Recent Challenges
Premium
Ratings
Inmune Bio’s Promising Pipeline and Strategic Positioning Support Buy Rating Despite Recent Challenges
2M ago
INMB
Inmune Bio Submits Manuscript on Alzheimer’s Trial
PremiumCompany Announcements
Inmune Bio Submits Manuscript on Alzheimer’s Trial
2M ago
8K
INMB
INmune Bio submits Phase 2 MINDFuL trial results to npj Dementia
PremiumThe Fly
INmune Bio submits Phase 2 MINDFuL trial results to npj Dementia
2M ago
INMB
INmune Bio completes first commercial manufacturing run of CORDStrom
PremiumThe Fly
INmune Bio completes first commercial manufacturing run of CORDStrom
2M ago
INMB
Inmune Bio’s Earnings Call: Progress Amid Challenges
PremiumCompany Announcements
Inmune Bio’s Earnings Call: Progress Amid Challenges
4M ago
INMB
Inmune Bio: Strategic Position and Growth Potential Amid Leadership Change and Promising Pipeline
PremiumRatingsInmune Bio: Strategic Position and Growth Potential Amid Leadership Change and Promising Pipeline
4M ago
INMB
INmune Bio Reports Q2 2025 Results and Strategic Updates
Premium
Company Announcements
INmune Bio Reports Q2 2025 Results and Strategic Updates
4M ago
INMB
INmune Bio CEO RJ Tesi retires, David Moss succeeds
Premium
The Fly
INmune Bio CEO RJ Tesi retires, David Moss succeeds
4M ago
INMB
INmune Bio reports Q2 EPS ($1.05), consensus (38c)
PremiumThe Fly
INmune Bio reports Q2 EPS ($1.05), consensus (38c)
4M ago
INMB
INmune Bio Completes Phase I/II Trial for INKmune™
PremiumCompany Announcements
INmune Bio Completes Phase I/II Trial for INKmune™
4M ago
8K
INMB
INmune Bio options imply 16.2% move in share price post-earnings
PremiumThe Fly
INmune Bio options imply 16.2% move in share price post-earnings
4M ago
INMB
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
4M ago
NNE
ARLP
INmune Bio reports Phase I/II trial of INKmune met primary, secondary endpoints
PremiumThe FlyINmune Bio reports Phase I/II trial of INKmune met primary, secondary endpoints
4M ago
INMB
INmune Bio options imply 14.9% move in share price post-earnings
Premium
The Fly
INmune Bio options imply 14.9% move in share price post-earnings
4M ago
INMB
INmune Bio Releases Video on Alzheimer’s Trial Results
Premium
Company Announcements
INmune Bio Releases Video on Alzheimer’s Trial Results
4M ago
8K
INMB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >